This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors

  • SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. STSA from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma Pharmaceuticals shares fell 3.8% to close at $5.36 on Friday.
  • UBS cut the price target for General Motors Company GM from $56 to $38. UBS analyst Patrick Hummel downgraded the stock from Buy to Neutral. GM shares fell 3.2% to $32.55 in pre-market trading.
  • JMP Securities cut the price target on Terreno Realty Corporation TRNO from $75 to $69. Terreno Realty shares fell 3.2% to close at $51.26 on Friday.
  • Barclays cut the price target for Turning Point Brands, Inc. TPB from $28 to $22. Turning Point Brands shares fell 1.9% to $20.83 in pre-market trading.
  • Keybanc cut the price target for Ventas, Inc. VTR from $60 to $56. Ventas shares fell 1.6% to close at $37.72 on Friday.
  • Mizuho lowered the price target on The Sherwin-Williams Company SHW from $288 to $264. Sherwin-Williams shares fell 5.2% to close at $205.60 on Friday.
  • Jefferies slashed the price target on Lincoln National Corporation LNC from $55 to $51. Lincoln National shares fell 0.2% to $46.70 in pre-market trading.

Check out this: Ford, General Motors And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Price Target
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading IdeasFinancialsLife & Health InsurancePT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!